Another study described KDM5A downregulation in CML-BP and found that KDM5A downregulated miR-21 expression by demethylation of H3K4me3 at the miR-21 promoter [98]. This evidence concerns the gene KDM5A and chronic myelogenous leukemia, BCR-ABL1 positive.